KYTX Bathi mangsa ngarep Kyverna Therapeutics Inc.

Kyverna - logo grafis emiten KYTX

Kyverna Therapeutics (KYTX) operates within a stable US legal framework, shielded from geopolitical risks by the humanitarian status of its developments. The company is expanding its scientific potential through partnerships with institutes to implement CAR-T therapy. The forward earnings metric demonstrates a balance between market demand and expectations, where the value serves as the target level. This confirms the successful adaptation of oncology technologies to eliminate the causes of autoimmune pathologies.

KYTX: Prakiraan bathi perusahaan Kyverna Therapeutics 04.07.2022 - 18.11.2026

Rincian analitis perusahaan Kyverna Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:KYTX, Kyverna
Barang utama Kyverna Therapeutics, Inc

For Kyverna Therapeutics (KYTX), whose T-cell modification patents create a formidable barrier to entry for competitors, forward financial results reflect the monetization potential of its unique therapy. This indicator extrapolates future revenues, neutralizing reporting gaps and identifying artificial trend smoothing, which allows investors to distinguish genuine asset value growth from speculative overheating amid strict FDA oversight.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Prakiraan bathi resik ZBIO (Zenas Biopharma, Inc.)|Bathi mangsa ngarep IMNM (Immunome Bio)|Prakiraan bathi perusahaan Gossamer Bio, Inc.|Proyeksi bathi mangsa ngarep KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Bathi resik sing dikarepake|PVLA - Bathi sing dikarepake|SVRA - Proyeksi bathi mangsa ngarep|Rigel Pharmaceuticals Inc (RIGL) - Bathi sing dikarepake|ANAB - Prakiraan bathi perusahaan|Bathi mangsa ngarep ATXS|ENGN: Penghasilan resik sing dikarepake|Bathi sing dikarepake RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ACRS (Aclaris Therapeutics)|Prakiraan bathi perusahaan Tiziana Life Sciences (TLSA)|Cabaletta Bio - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Ventyx Biosciences, Inc. VTYX|Theratechnologies Inc (THTX) - Bathi sing dikarepake|Bathi forward AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep agenusbio.com|Proyeksi bathi mangsa ngarep CLYM|Bathi resik mangsa ngarep ZURA|Proyeksi bathi mangsa ngarep ATYR (aTyr Pharmaceuticals)|Penghasilan resik sing dikarepake ADAG|ImageneBio Inc - Proyeksi bathi mangsa ngarep|STTK (shattucklabs.com) - Prakiraan bathi resik|EQ: Proyeksi bathi mangsa ngarep|Connect Biopharma Holdings (CNTB) - Proyeksi bathi mangsa ngarep|IMUX (immunic-therapeutics.com) - Proyeksi bathi mangsa ngarep|ATRA (Atara Biotherapeutics) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep IFRX|Proyeksi bathi mangsa ngarep X4 Pharmaceuticals, Inc (XFOR)|Proyeksi bathi mangsa ngarep ACET (Adicet Bio Inc.)|CELU (Celularity Corp) - Bathi forward|INmune Bio Corp - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep